Annals of Colorectal Research

Published by: Kowsar
Crossmark

Prevalence of Neuroendocrine Tumors in the Gastrointestinal and Hepatobiliary Systems

Modesto J Varas Lorenzo 1 , 2 , 3 , Fernando Munoz Agel ORCID 1 , 2 , Ramon Abad Belando 2 and Elena Sanchez-Vizcaino Mengual ORCID 4 , *
Authors Information
1 Echoendoscopy Unit and Department of Gastroenterology, Teknon Medical Center, Barcelona, Spain
2 Echoendoscopy Unit and Department of Gastroenterology, Hospital Sanitas CIMA, Barcelona, Spain
3 Facultat de Ciencias de la Salud, Universitat Oberta de Catalunya (UOC), Barcelona, Spain
4 PMO, i2e3 Biomedical Research Institute, Barcelona, Spain
Article information
  • Annals of Colorectal Research: June 30, 2019, 7 (2); e88004
  • Published Online: July 16, 2019
  • Article Type: Research Article
  • Received: December 20, 2018
  • Revised: June 16, 2019
  • Accepted: July 2, 2019
  • DOI: 10.5812/acr.88004

How to Cite: Varas Lorenzo M J, Munoz Agel F, Abad Belando R, Sanchez-Vizcaino Mengual E. Prevalence of Neuroendocrine Tumors in the Gastrointestinal and Hepatobiliary Systems, Ann Colorectal Res. 2019 ; 7(2):e88004. doi: 10.5812/acr.88004.

Abstract
Copyright © 2019, Annals of Colorectal Research. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Oberndorfer S. Karzinoide tumoren des dünndarms. 1. Frankf Z Pathol; 1907. p. 425-32. German.
  • 2. Sanders RJ. Carcinoids of the gastrointestinal tract. Surg Gynecol Obstet. 1964;119:369-80.
  • 3. Macdonald RA. A study of 356 carcinoids of the gastrointestinal tract; report of four new cases of the carcinoid syndrome. Am J Med. 1956;21(6):867-78. doi: 10.1016/0002-9343(56)90101-2. [PubMed: 13372563].
  • 4. Buchanan KD, Johnston CF, O'Hare MMT, Ardill JES, Shaw C, Collins JSA, et al. Neuroendocrine tumors: A European view. Am J Med. 1986;81(6):14-22. doi: 10.1016/0002-9343(86)90581-4.
  • 5. Hemminki K, Li X. Incidence trends and risk factors of carcinoid tumors: A nationwide epidemiologic study from Sweden. Cancer. 2001;92(8):2204-10. doi: 10.1002/1097-0142(20011015)92:8<2204::aid-cncr1564>3.0.co;2-r. [PubMed: 11596039].
  • 6. Berge T, Linell F. Carcinoid tumours. Frequency in a defined population during a 12-year period. Acta Pathol Microbiol Scand A. 1976;84(4):322-30. [PubMed: 961424].
  • 7. Clemente C, Puig V, Mirada A. [Carcinoid tumor Analysis of 131 cases]. Rev Clin Esp. 1994;194:291-3. Spanish.
  • 8. Godwin JD 2nd. Carcinoid tumors. An analysis of 2,837 cases. Cancer. 1975;36(2):560-9. doi: 10.1002/1097-0142(197508)36:2<560::aid-cncr2820360235>3.0.co;2-4. [PubMed: 1157019].
  • 9. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997;79(4):813-29. doi: 10.1002/(sici)1097-0142(19970215)79:4<813::aid-cncr19>3.0.co;2-2. [PubMed: 9024720].
  • 10. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after "carcinoid": Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26(18):3063-72. doi: 10.1200/JCO.2007.15.4377. [PubMed: 18565894].
  • 11. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97(4):934-59. doi: 10.1002/cncr.11105. [PubMed: 12569593].
  • 12. Kang H, O'Connell JB, Leonardi MJ, Maggard MA, McGory ML, Ko CY. Rare tumors of the colon and rectum: A national review. Int J Colorectal Dis. 2007;22(2):183-9. doi: 10.1007/s00384-006-0145-2. [PubMed: 16845516].
  • 13. Younes RN; Grupo de Estudo de Tumores Neuroendocrinos (Getne). Neuroendocrine tumors: A registry of 1,000 patients. Rev Assoc Med Bras (1992). 2008;54(4):305-7. [PubMed: 18719787].
  • 14. Rosch T, Lightdale CJ, Botet JF, Boyce GA, Sivak MV Jr, Yasuda K, et al. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med. 1992;326(26):1721-6. doi: 10.1056/NEJM199206253262601. [PubMed: 1317506].
  • 15. Zimmer T, Ziegler K, Liehr RM, Stolzel U, Riecken EO, Wiedenmann B. Endosonography of neuroendocrine tumors of the stomach, duodenum, and pancreas. Ann N Y Acad Sci. 1994;733:425-36. doi: 10.1111/j.1749-6632.1994.tb17292.x. [PubMed: 7978891].
  • 16. Yoshida M, Tsukamoto Y, Niwa Y, Goto H, Hase S, Hayakawa T, et al. Endoscopic assessment of invasion of colorectal tumors with a new high-frequency ultrasound probe. Gastrointest Endosc. 1995;41(6):587-92. [PubMed: 7672554].
  • 17. Varas Lorenzo MJ. [Pharmacological treatment of gastroenteropancreatic apudomas with the somatostatin analog SMS 201-995 (octeotride)]. Rev Esp Enferm Dig. 1991;79:95-8. Spanish.
  • 18. Modlin IM, Gilligan CJ, Lawton GP, Tang LH, West AB, Darr U. Gastric carcinoids. The Yale Experience. Arch Surg. 1995;130(3):250-5. discussion 255-6. doi: 10.1001/archsurg.1995.01430030020003. [PubMed: 7887791].
  • 19. Modlin IM, Lye KD, Kidd M. A 50-year analysis of 562 gastric carcinoids: Small tumor or larger problem? Am J Gastroenterol. 2004;99(1):23-32. [PubMed: 14687136].
  • 20. Modlin IM, Champaneria MC, Chan AK, Kidd M. A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: The rapid pace of no progress. Am J Gastroenterol. 2007;102(7):1464-73. doi: 10.1111/j.1572-0241.2007.01185.x. [PubMed: 17391319].
  • 21. Martensson H, Nobin A, Sundler F. Carcinoid tumors in the gastrointestinal tract--an analysis of 156 cases. Acta Chir Scand. 1983;149(6):607-16. [PubMed: 6650073].
  • 22. Gustafsson BI, Kidd M, Chan A, Malfertheiner MV, Modlin IM. Bronchopulmonary neuroendocrine tumors. Cancer. 2008;113(1):5-21. doi: 10.1002/cncr.23542. [PubMed: 18473355].
  • 23. Varas Lorenzo MJ. Neuroendocrine tumors: Fascination and infrequency. Rev Esp Enferm Dig. 2009;101(3). doi: 10.4321/s1130-01082009000300006.
  • 24. Maggard MA, O'Connell JB, Ko CY. Updated population-based review of carcinoid tumors. Ann Surg. 2004;240(1):117-22. doi: 10.1097/01.sla.0000129342.67174.67. [PubMed: 15213627]. [PubMed Central: PMC1356383].
  • 25. Pinchot SN, Holen K, Sippel RS, Chen H. Carcinoid tumors. Oncologist. 2008;13(12):1255-69. doi: 10.1634/theoncologist.2008-0207. [PubMed: 19091780]. [PubMed Central: PMC2901509].
  • 26. Scherubl H. Rectal carcinoids are on the rise: Early detection by screening endoscopy. Endoscopy. 2009;41(2):162-5. doi: 10.1055/s-0028-1119456. [PubMed: 19214898].
  • 27. Kaminski MF, Polkowski M, Regula J. Prevalence and endoscopic features of rectal neuro-endocrine tumours among 50 148 participants of the Polish Colorectal-Cancer Screening Programme. Gut. 2007;56. A310.
  • 28. Mulkeen A, Cha C. Gastric carcinoid. Curr Opin Oncol. 2005;17(1):1-6. [PubMed: 15608504].
  • 29. Landry CS, Brock G, Scoggins CR, McMasters KM, Martin RC 2nd. A proposed staging system for gastric carcinoid tumors based on an analysis of 1,543 patients. Ann Surg Oncol. 2009;16(1):51-60. doi: 10.1245/s10434-008-0192-8. [PubMed: 18953609].
  • 30. Massironi S, Sciola V, Spampatti MP, Peracchi M, Conte D. Gastric carcinoids: Between underestimation and overtreatment. World J Gastroenterol. 2009;15(18):2177-83. doi: 10.3748/wjg.15.2177. [PubMed: 19437556]. [PubMed Central: PMC2682231].
  • 31. Varas MJ, García F, Barrios P, Borrell J. [Carcinoid tumors of the digestive system]. Med Clin. 1985;17:715-6. Spanish.
  • 32. Varas MJ. Tumores de los islotes pancreaticos. In: Vilardell F, Rodes J, Malagelada JR, Pajares J M, Perez M, editors. Enfermedades Digestivas. 2. Madrid-Barcelona: Aula Médica; 1998. p. 1516-24. Spanish.
  • 33. Varas Lorenzo MJ, Munoz Agel F, Espinos Perez JC, Bardaji Bofill M. [Digestive carcinoid tumors]. Rev Esp Enferm Dig. 2010;102(9):533-7. Spanish.
  • 34. Rorstad O. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract. J Surg Oncol. 2005;89(3):151-60. doi: 10.1002/jso.20179. [PubMed: 15719376].
  • 35. McMullen T, Al-Jahdali A, de Gara C, Ghosh S, McEwan A, Schiller D. A population-based study of outcomes in patients with gastrointestinal neuroendocrine tumours. Can J Surg. 2017;60(3):192-7. doi: 10.1503/cjs.007616. [PubMed: 28327275]. [PubMed Central: PMC5453762].
  • 36. Cesar D, Zanatto RM, da Silva MV, Golcalves R, de Mello EL, de Jesus JP. Colon and rectum neuroendocrine tumors: Experience of the National Cancer Institute in Brazil. Arq Bras Cir Dig. 2013;26(1):36-9. [PubMed: 23702868].
  • 37. Mocellin S, Nitti D. Gastrointestinal carcinoid: epidemiological and survival evidence from a large population-based study (n = 25 531). Ann Oncol. 2013;24(12):3040-4. doi: 10.1093/annonc/mdt377. [PubMed: 24050954].
  • 38. Soga J. Carcinoids and their variant endocrinomas. An analysis of 11842 reported cases. J Exp Clin Cancer Res. 2003;22(4):517-30. [PubMed: 15053292].
  • 39. Ono A, Fujii T, Saito Y, Matsuda T, Lee DT, Gotoda T, et al. Endoscopic submucosal resection of rectal carcinoid tumors with a ligation device. Gastrointest Endosc. 2003;57(4):583-7. doi: 10.1067/mge.2003.142. [PubMed: 12665777].
  • 40. Martinez-Ares D, Souto-Ruzo J, Varas Lorenzo MJ, Espinos Perez JC, Yanez Lopez J, Abad Belando R, et al. Endoscopic ultrasound-assisted endoscopic resection of carcinoid tumors of the gastrointestinal tract. Rev Esp Enferm Dig. 2004;96(12):847-55. [PubMed: 15634185].
  • 41. Aguirre A, Cosme A, Bujanda L, Navascues JE, Larburu S, Larzabal M, et al. Diagnosis, treatment and follow-up of gastric carcinoid tumors. Analysis of 14 cases. Rev Esp Enferm Dig. 2011;103(9):493-4. [PubMed: 21951121].
  • 42. Yuksel O. Gastric carcinoid tumors: The problems encountered in diagnosis and treatment. Int J Hematol Oncol. 2013;23(2):104-8. doi: 10.4999/uhod.10034.
  • 43. Varas-Lorenzo MJ, Gornals JB, Munoz F, Loras C, Cruz M, Espinos JC, et al. [Gastric carcinoid tumors: An analysis of 24 cases]. Rev Esp Enferm Dig. 2013;105(10). Spanish. doi: 10.4321/s1130-01082013001000013.
  • 44. Teleky B, Herbst F, Längle F, Neuhold N, Niederle B. The prognosis of rectal carcinoid tumours. Int J Colorectal Dis. 1992;7(1):11-4. doi: 10.1007/bf01647653.
  • 45. Weinstock B, Ward SC, Harpaz N, Warner RR, Itzkowitz S, Kim MK. Clinical and prognostic features of rectal neuroendocrine tumors. Neuroendocrinology. 2013;98(3):180-7. doi: 10.1159/000355612. [PubMed: 24080744].
  • 46. Mashimo Y, Matsuda T, Uraoka T, Saito Y, Sano Y, Fu K, et al. Endoscopic submucosal resection with a ligation device is an effective and safe treatment for carcinoid tumors in the lower rectum. J Gastroenterol Hepatol. 2008;23(2):218-21. doi: 10.1111/j.1440-1746.2008.05313.x. [PubMed: 18289355].
  • 47. Vilallonga R, Espin Basany E, Lopez Cano M, Landolfi S, Armengol Carrasco M. [Neuroendocrine carcinomas of the colon and rectum: One unit experience in six years]. Rev Esp Enferm Dig. 2008;100(1). Spanish. doi: 10.4321/s1130-01082008000100003.
  • 48. Grin A, Streutker CJ. Neuroendocrine tumors of the luminal gastrointestinal tract. Arch Pathol Lab Med. 2015;139(6):750-6. doi: 10.5858/arpa.2014-0130-RA. [PubMed: 26030244].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments